CNXU CNXU
Company Profile ↓Company Overview
CNXU (CNXU) is a publicly traded company listed on with a market capitalization of $188.04M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- 5-Year Trend Long-term compounding — profit CAGR -731.5%.
Growth & Price Performance
Compounded Profit Growth
| 5 Years: | -731.50% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -31.22% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | -5.27% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- RSI (14)49.19 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Earnings shrank at -731.5% CAGR over 5 years.
- Trading 46.6% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jan 2025 | Apr 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 332.72K | 456.06K | 1.72M | 2.38M |
| Operating Income | -332.72K | -456.06K | -1.72M | -2.38M |
| EBITDA | -285.89K | -453.27K | -1.71M | -2.29M |
| Interest Expense | 3.61K | 1.38K | 0 | 0 |
| Pretax Income | -290.06K | -458.05K | -1.72M | -2.30M |
| Tax Provision | 0 | 0 | 0 | 0 |
| Net Income | -290.06K | -458.05K | -1.72M | -2.30M |
| Diluted EPS | -0.01 | -0.02 | -0.08 | -0.11 |
| R&D Expense | - | 42.47K | - | 66.61K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Oct 2024 | Oct 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | 643.04K | 3.96M |
| Operating Income | -643.04K | -3.96M |
| EBITDA | -455.36K | -3.90M |
| Interest Expense | 16.50K | 4.95K |
| Pretax Income | -471.87K | -3.92M |
| Tax Provision | 0 | 0 |
| Net Income | -471.87K | -3.92M |
| Diluted EPS | -0.02 | -0.19 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Oct 2024 | Oct 2025 |
|---|---|---|
| Total Assets | 533.94K | 7.69M |
| Current Assets | 347.24K | 7.46M |
| Cash & Equivalents | 314.62K | 4.81M |
| Inventory | - | - |
| Receivables | 0 | 2.07M |
| Total Liabilities | 438.98K | 336.02K |
| Current Liabilities | 340.86K | 336.02K |
| Long Term Debt | 98.12K | - |
| Total Debt | 98.12K | - |
| Total Equity | 94.96K | 7.35M |
| Shares Outstanding | 20.92M | 20.92M |
Cash Flows (Annual)
Figures in USD.
| Metric | Oct 2024 | Oct 2025 |
|---|---|---|
| Operating Cash Flow | -225.44K | -1.67M |
| Investing Cash Flow | 0 | -89.99K |
| Financing Cash Flow | 534.64K | 6.28M |
| Capital Expenditure | - | -18.67K |
| Free Cash Flow | -225.44K | -1.69M |
| Net Change in Cash | 309.20K | 4.52M |
Ratios (Annual)
Figures in %.
| Metric | Oct 2024 | Oct 2025 |
|---|---|---|
| Gross Margin % | - | - |
| Operating Margin % | - | - |
| Net Margin % | - | - |
| ROE % | -496.9% | -53.4% |
| ROCE % | -333.0% | -53.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CNXU
Top Conexeu Sciences (CNXU) Competitors 2026 - MarketBeat
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPeEF1enphcDI3aGo2VUdDd1RiNjZvZko2ZEdaMlo0MVMxR2ZiTGNjM19KNFU0dkQtZHFOeVhIYlpXaldVc01JZDZDSHd4V2NRX2dXaDBad0dXaW94M1EtbjZQNUxwbHVYamE1NlpXbjBaT2R0SkM5aGVLbjQwclhTTw?oc=5" target="_…
$CNXU stock is up 17% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNQlZxMTRQYmtpSEpJWEpTOWxTRUpEZHVkSmtEUzU2a283SG1GU2duNThfcHdURENFUjBIMlF5WnNORFdUZXkwOVdvT2txczl0QUJ4UG0zQXdVUTlXZkVZcEllMU12dndUV3duNW05aEVZUmt4R3JJSVBaNW9Kcm9reFVERGFSVlhMdGdwSz…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE11bkRPX3EtVzlVT2VhT3lET3lWVnNaeGdtaGQxRlBxNTFmdmV6MjZEYk9qekhfZ2xFMS15c2lPYkJqc2tqci01Ti02MFNUT3po?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
CNXU Stock Price and Chart — NASDAQ:CNXU - TradingView
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1MSWpSUkdOeVNWYzNIZ0NtSVdfT1h2andRV2tXN25VMXl6aHl2dUpLZVo4STlvOEZQcWVPTEh5TFBvS19abGY2NTBhYjFRLUhXeVg0VC1FS19abHY3?oc=5" target="_blank">CNXU Stock Price and Chart — NASDAQ:CNXU</a…
Conexeu Sciences (CNXU) Stock Trends and Sentiment 2026 - MarketBeat
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE5oLXBCcjdGTFYzRExXWlUxa2VOVkpNUXkxNHBQSmNIblJ4UkNYbTlVM1Q2VmNRdmJiUkFreTVweGhIZkpfd0ZNdVZ2a0pKelktQ1ppcEgzU2JuWDRHQ0hRXzQ3R1ZiT2lMZGoxYkxKR21XVy1EeEE?oc=5" target="_blank">Conexeu …
Conexeu Sciences (CNXU) Stock Could Be 47.6% Undervalued After FDA Prep And Leadership Moves - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxOWE0tU3h6dVBGdlNxaG1tN29PWFB4dDJQMmpmc01fWFY2NHgxVWlPeWNtSUZ1Wl82Wi1pRXFvNUF2c19zV3RRbkJEb2JOQ3NtdGQxOVY2NHdFc3JoTUZjcU1mdzM0aTJuVWRwLWhYQVhBenNLNm5NZkZXR05MNjB0YTBGY1N3SnFGNUl5R1…
CNXU — Frequently Asked Questions
What is the current share price of CNXU?
As of 2026-08-05 17:25 PDT, CNXU trades at $8.99 on NASDAQ/NYSE. Its 52-week range is $7.68 to $16.85.
What is the market capitalisation of CNXU?
CNXU has a market capitalisation of $188.04M on NASDAQ/NYSE.
What is the P/E ratio of CNXU?
CNXU trades at a trailing price-to-earnings (P/E) ratio of -47.92. Its price-to-book (P/B) ratio is 25.58.
What is the return on equity (ROE) of CNXU?
CNXU has a return on equity (ROE) of -53.36%. Its return on capital employed (ROCE) is -53.29%.
Is CNXU a good stock to buy?
This page provides a data-driven analysis of CNXU, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.